Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases.
Jagoda PokryszkaAngelika WagnerUrsula WiedermannSelma TobudicHarald HerknerStefan WinklerSonja BrehovskyWalter ReinischGottfried NovacekPublished in: Vaccines (2022)
Our findings support possible collinearity in pathways of SARS-CoV-2 antigen expression and the pathogenesis of IBD.